C&M International is a global government relations, public policy, and public affairs firm that helps clients shape the legal, regulatory, and commercial landscape in key international markets.

For more than three decades, we’ve advised the world’s leading companies and associations on how to partner for impact with those who are creating policy for the 21st-century global economy.

The Issues What We Know Best

The policy and regulatory areas where we engage policymakers, advance client objectives, and create lasting impact.

Our commitment to making an impact on society goes beyond delivering medicines that can help to create, improve and prolong life. CMI helped us to design one of our flagship purpose-driven initiatives and continues to support meaningful collaborations to advance the health and well-being of women.

Lynn Taylor

Senior Vice President, Head of Healthcare Global Government and Public Affairs, EMD Serono
the Healthcare Business of Merck KGaA, Darmstadt, Germany (Washington, DC)

CMI is a leading voice in Washington, DC for American Chambers of Commerce based around the world.
From the halls of Congress to the White House, from U.S.-China trade negotiations to media strategy,
we rely upon the CMI team to translate our objectives into effective advocacy.

Ker Gibbs

President, American Chamber of Commerce in Shanghai

Ocean Conservancy recognizes that to solve the ocean plastic crisis we need to attract more investment and we need new partnerships. CMI helped us secure political endorsement from APEC Foreign and Trade Ministers on a set of recommendations to address barriers to financing waste management systems and developed a multi-stakeholder platform to promote innovative solutions to marine litter in the Asia-Pacific region.

Doug Cress

Former Vice President, Conservation, Ocean Conservancy (Washington, DC)

When we needed to build an industry coalition spanning the Americas, we turned to CMI for a turnkey solution.
CMI executed so flawlessly that we are now partnering on a multi-year project
to build government regulatory capacity in the COVID-19 era.

Steven Bipes

Vice President, Global Strategy and Analysis,
Advanced Medical Technology Association (AdvaMed) (Washington, DC)